Meet OPEN Health and Pharmerit Experts at the World Pharma Pricing Market Access and Evidence Congress 2020
September 10, 2020 |
Join OPEN Health and Pharmerit – an OPEN Health Company at the World Pharma Pricing Market Access and Evidence Congress from 23 – 25 September 2020, as we present:
ROUNDTABLE: Wednesday, September 23, 13:00
Exploring Digital Therapeutics
Moderated by: Olaf Schoeman, MSc, Director and German Lead
Presentation: Thursday, September 24, 14:30
EUnetHTA Joint Assessments and Implications for the Industry
Rosemary Jose, PhD, Director and Commercial Lead, Strategic Market Access
We welcome you to schedule a meeting with one of our team members Rosemary Jose, Olaf Schoeman, Marja Hensen, Walter Bouwmeester, Andrew Revel, Marie Keetley or Phil Drew to discuss your market access, HEOR and real-world evidence needs.
OPEN Health is a family of expert practices working in partnership to drive positive change in healthcare communications and market access globally. It all started with a vision to create a new, unique entity equipped to be a global leader in HEOR, market access, medical and patient brand communications and digital services. By bringing together the Pharmerit and OPEN VIE teams to create the Evidence and Access practice, we have expanded our global footprint and capabilities in HEOR and market access. This newly integrated team provides world-class knowledge, insight and outputs across the entire spectrum of market access and reimbursement, evidence generation, gathering and evaluation, and population-based health data. Our multidisciplinary teams work across four centers of excellence:
Together, we have grown to over 700 people in 15 offices across 6 different countries including US, UK, The Netherlands, Germany, India and China. What makes us different is our deeply integrated teams working collaboratively to bring the strategic and technical expertise needed to be a solid partner to our sponsors. Combine this with our broad scope of therapeutic expertise to produce results and solutions that are of the highest quality. We pride ourselves on having a highly skilled, diverse, and connected team working across the globe to deliver truly innovative and best-in-class solutions. This has resulted in long-term, flexible partnerships that span many years across multiple brands and therapy areas.
For more information on how we are improving the lives of patients, worldwide, please visit www.openhealthgroup.com
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
Spotlight interview: 15 minutes on medical and scientific writing
Rob Pilbrow, Global Managing Director, Medical Writing, OPEN Health takes 15 minutes to answer some key questions on scientific writing
Spotlight interview: 15 minutes on healthcare advertising
Marie Little, Managing Director, OPEN Health Patient & Brand Communications takes 15 minutes to answer some key questions on healthcare advertising
Alexander Devine Website has gone live!
As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly...
Spotlight interview: 15 minutes on patient-centricity in pharma
Sumira Riaz, Health Psychologist at OPEN Health Patient & Brand Communications, takes 15 minutes to answer some key questions on patient-centricity in pharma.
Spotlight interview: 15 minutes on patient engagement in pharma
Richard Jones, Managing Director Patient Engagement, OPEN Health Patient and Brand Communications, takes 15 minutes to answer some key questions on patient engagement in pharma
Rob Pilbrow joins OPEN Health as Global Managing Director, Medical Writing
OPEN Health Group have appointed Rob Pilbrow into the newly formed role of Global Managing Director, Medical Writing.
Spotlight interview: 15 minutes on the procurement function in pharma
Carwyn Jones, Senior Partner at OPEN Health, takes 15 minutes to answer some key questions on the procurement function in pharma.
Precision medicine with precision management and precision pricing; ensuring affordability in the cell and gene therapy era
The third plenary session at ISPOR in New Orleans focused on affordability in the face of new and expensive therapies and asked the question “is affordability driving a need to...
OPEN Health Medical Communications announces Group MD promotions and welcomes new Creative Director
OPEN Health Medical Communications has announced the promotion of two members of its senior leadership team. Jen van Zwieten and Margot Hannah become Group Managing Directors, with responsibility to oversee...
OPEN Health Graduates and the XP Support Group
During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...